IDEAYA Biosciences hauls in $94 mln
South San Francisco-based IDEAYA Biosciences Inc, an oncology-focused biotechnology company, has closed $94 million in financing. The investors included BVF Partners L.P., Perceptive Advisors LLC, Nextech Invest Ltd, GV, Roche Venture Fund, 6 Dimensions Capital, Boxer Capital of the Tavistock Group, Driehaus Capital Management, LLC, 5AM Ventures, Canaan Partners, Celgene Corporation, WuXi Healthcare Ventures and Alexandria Venture Investments.
15 March 2018•1 min read
